Search

Volumetric 3D displays are frequently purported to lack the ability to reconstruct scenes with viewer-position-dependent effects such as occlusion. To counter these claims, a swept-screen 198-view horizontal-parallax-only 3D display is reported here that is capable of viewer-position-dependent effects. A digital projector illuminates a rotating vertical diffuser with a series of multiperspective 768 x 768 pixel renderings of a 3D scene. Evidence of near-far object occlusion is reported. The aggregate virtual screen surface for a stationary observer is described, as are guidelines to construct a full-parallax system and the theoretical ability of the present system to project imagery outside of the volume swept by the screen. OCIS codes: 080.2740, 090.1760, 090.2870, 090.4220, 100.6890, 350.4600.

Objective: We sought to determine the effect of montelukast, a leukotriene receptor antagonist, on intradermal skin testing. Study design and setting We conducted a prospective, randomized, double-blind, placebo-controlled study in a university setting., Methods: After a 1-week washout of allergy pharmacotherapy, intradermal skin testing was performed on 23 atopic subjects. Whealing size was measured 20 minutes after injection. Subjects then began a 1-week regimen of daily loratadine, montelukast, or placebo. At 1 week, subjects again underwent intradermal skin testing. The change in wheal size was then calculated from baseline., Results: A significant difference (P < 0.05) between the montelukast and loratadine groups in suppression of intradermal whealing at 1 week was observed. No significant difference was noted between the montelukast and placebo subjects., Conclusions: Montelukast demonstrated no significant suppression of skin whealing after antigen challenge over placebo., Significance: Montelukast does not need to be discontinued before intradermal allergy testing.